A team of UCL researchers, led by Professor Anthony Schapira (UCL Queen Square Institute of Neurology) are expected to launch a phase 3 clinical trial with the active ingredient of cough remedies, ambroxol, to assess its effectiveness in hundreds of people with Parkinson’s.
Read: Mirror
Close
